MedTrace Logo

Clinical Evaluation of Cervical Ripening in the Outpatient Setting

NCT04271722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2024-05-31

No results posted yet for this study

Summary

A randomized controlled trial of mifepristone 200mg vs balloon catheter for cervical ripening.

Conditions

  • Labor; Forced or Induced, Affecting Fetus or Newborn
  • Labor Onset and Length Abnormalities

Interventions

OTHER

Cervical ripening

Subjects will undergo cervical ripening in the outpatient setting. The patients will then be scheduled to return the next morning for induction of labor.

Sponsors & Collaborators

  • Centro Hospitalar Lisboa Norte

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04271722 on ClinicalTrials.gov